- Motley Fool•yesterday
The drugmaker announced a delay to approval of its three-times-weekly version of Glatopa.
- Market Realist•2 days ago
In 2016, Enbrel’s sales totaled ~$5.5 billion, which is a year-over-year rise of around 3.2%.
- Motley Fool•4 days ago
GlaxoSmithKline and Novartis are two high-yield dividend stocks that might be grossly undervalued.
NVS : Summary for Novartis AG Common Stock - Yahoo Finance
Novartis AG (NVS)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||76.48 - 77.11|
|52 Week Range||66.93 - 83.58|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||27.45|
|Dividend & Yield||2.75 (3.56%)|
|1y Target Est||N/A|